Growth Metrics

Nephros (NEPH) Non-Current Debt (2016 - 2022)

Nephros' quarterly Non-Current Debt came in at $100000.0 in Q4 2022, up 5.26% year-on-year from $95000.0 in Q4 2021, and down 50.0% quarter-over-quarter from $200000.0 in Q2 2022.

Nephros has reported Non-Current Debt for 7 years, with the latest figure at $100000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Non-Current Debt rose 5.26% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2022 stood at $100000.0 (up 5.26% YoY), and the FY2022 full-year result was $100000.0, up 5.26% from the prior year.
  • Non-Current Debt for Q4 2022 stood at $100000.0, down from $200000.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $1.0 million in Q1 2018, with the low at $24000.0 in Q1 2022.
  • Average Non-Current Debt over 5 years is $488263.2, with a median of $491000.0 recorded in 2020.
  • Year-over-year, Non-Current Debt climbed 16.31% in 2021 and slumped 91.97% in 2022.
  • Tracing NEPH's Non-Current Debt over 5 years: stood at $843000.0 in 2018, then dropped by 27.28% to $613000.0 in 2019, then fell by 21.37% to $482000.0 in 2020, then slumped by 80.29% to $95000.0 in 2021, then climbed by 5.26% to $100000.0 in 2022.
  • The last three Non-Current Debt figures came in at $100000.0 (Q4 2022), $200000.0 (Q2 2022), and $24000.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 14.71 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 202.80 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 4.58 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 1.88 Bn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 8.62 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.14 Bn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 100,000.00
Dec 31, 2022 100,000.00
Jun 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 24,000.00
Mar 31, 2022 24,000.00
Dec 31, 2021 95,000.00
Dec 31, 2021 95,000.00
Sep 30, 2021 164,000.00
Sep 30, 2021 164,000.00
Jun 30, 2021 232,000.00
Jun 30, 2021 232,000.00
Mar 31, 2021 299,000.00
Mar 31, 2021 299,000.00
Dec 31, 2020 482,000.00
Dec 31, 2020 482,000.00
Sep 30, 2020 141,000.00
Sep 30, 2020 141,000.00
Jun 30, 2020 491,000.00
Jun 30, 2020 491,000.00
Mar 31, 2020 553,000.00
Mar 31, 2020 553,000.00
Dec 31, 2019 613,000.00
Dec 31, 2019 613,000.00
Sep 30, 2019 672,000.00
Sep 30, 2019 672,000.00
Jun 30, 2019 730,000.00
Jun 30, 2019 730,000.00
Mar 31, 2019 787,000.00
Mar 31, 2019 787,000.00
Dec 31, 2018 843,000.00
Dec 31, 2018 843,000.00
Sep 30, 2018 897,000.00
Sep 30, 2018 897,000.00
Jun 30, 2018 951,000.00
Jun 30, 2018 951,000.00
Mar 31, 2018 1.00 Mn
Mar 31, 2018 1.00 Mn
Dec 31, 2017 954,000.00
Dec 31, 2017 954,000.00
Sep 30, 2017 922,000.00
Sep 30, 2017 922,000.00
Jun 30, 2017 892,000.00
Jun 30, 2017 892,000.00
Mar 31, 2017 864,000.00
Mar 31, 2017 864,000.00
Dec 31, 2016 838,000.00
Dec 31, 2016 838,000.00
Sep 30, 2016 814,000.00
Sep 30, 2016 814,000.00
Jun 30, 2016 791,000.00
Jun 30, 2016 791,000.00